Educational content on VJOncology is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

BTOG 2020 | Incidence of pneumonitis in patients undergoing immunotherapy

Alastair Greystoke • 30 Jan 2020
BTOG 2020
Lung Cancer

Alastair Greystoke, MBChB, MSc, PhD, MRCP, Northern Institute for Cancer Research, Newcastle University, Newcastle, UK, outlines the problem of pneumonitis associated with immunotherapy. It was shown that 10% of lung cancer patients were admitted with pneumonitis, with this group experiencing poorer survival outcomes. This interview took place at the 18th British Thoracic Oncology Group (BTOG) 2020 congress held in Dublin, UK

More from Alastair Greystoke

6:20
Solid tumor genomic testing in the UK: challenges and solutions
Alastair Greystoke • 28 Apr 2023
1:51
NHS England: a pilot ctDNA study to track patient responses to novel genomic targets
Alastair Greystoke • 27 Apr 2023
5:59
Deciphering an NGS report in lung cancer
Alastair Greystoke • 24 Jan 2022
3:34
Strategies to improve biomarker testing in the UK
Alastair Greystoke • 24 Jan 2022

Related Videos

3:35
Lung cancer initiation: towards molecular cancer prevention
Charles Swanton • 18 Apr 2024
0:37
STABLE-MATES: sublobar resection vs SAbR in high-risk patients with stage I NSCLC
Clive Peedell • 18 Apr 2024
0:44
BTOG 2024: networking highlights and insights
Clive Peedell • 18 Apr 2024
0:49
Ongoing trials in thoracic radiotherapy: evaluating current role and significance
Thomas Newsom-Davis • 18 Apr 2024
The content of VJOncology is intended for healthcare professionals